INCYTE CORPORATION Costs and Expenses
INCYTE CORPORATION (INCY) reported Costs and Expenses of $971.56 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2026-04-28
- INCYTE CORPORATION costs and expenses for the quarter ending 2026-03-31 was $971.56M, a 14.61% increase year-over-year.
- INCYTE CORPORATION costs and expenses for the quarter ending 2025-12-31 was $1.17B, a 33.49% increase year-over-year.
- INCYTE CORPORATION costs and expenses for the quarter ending 2025-09-30 was $922.46M, a 6.99% decline year-over-year.
- INCYTE CORPORATION costs and expenses for the quarter ending 2025-06-30 was $685.22M, a 54.98% decline year-over-year.
- INCYTE CORPORATION costs and expenses for fiscal 2025 was $3.63B, a 13.24% decline from fiscal 2024.
- INCYTE CORPORATION costs and expenses for fiscal 2024 was $4.18B, a 35.92% increase from fiscal 2023.
- INCYTE CORPORATION costs and expenses for fiscal 2023 was $3.08B, a 9.23% increase from fiscal 2022.
- INCYTE CORPORATION costs and expenses for fiscal 2022 was $2.82B, a 17.28% increase from fiscal 2021.
| Period end | Costs and Expenses 3 month | Costs and Expenses 3 month as first filed | Costs and Expenses 6 month | Costs and Expenses 6 month as first filed | Costs and Expenses 9 month | Costs and Expenses 9 month as first filed | Costs and Expenses 12 month | Costs and Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $971.56M 10-Q · filed 2026-04-28 | $2.14B derived: sum of 2 quarters · filed 2026-04-28 | $3.06B derived: sum of 3 quarters · filed 2026-04-28 | $3.75B derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2025-12-31 | $1.17B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $2.09B derived: sum of 2 quarters · filed 2026-02-10 | $2.78B derived: sum of 3 quarters · filed 2026-02-10 | $3.63B 10-K · filed 2026-02-10 | ||||
| 2025-09-30 | $922.46M 10-Q · filed 2025-10-28 | $1.61B derived: sum of 2 quarters · filed 2025-10-28 | $2.46B 10-Q · filed 2025-10-28 | $3.33B derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2025-06-30 | $685.22M 10-Q · filed 2025-07-29 | $1.53B 10-Q · filed 2025-07-29 | $2.41B derived: sum of 3 quarters · filed 2026-04-28 | $3.40B derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2025-03-31 | $847.73M 10-Q · filed 2026-04-28 | $1.72B derived: sum of 2 quarters · filed 2026-04-28 | $2.72B derived: sum of 3 quarters · filed 2026-04-28 | $4.24B derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2024-12-31 | $877.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $1.87B derived: sum of 2 quarters · filed 2026-02-10 | $3.39B derived: sum of 3 quarters · filed 2026-02-10 | $4.18B 10-K · filed 2026-02-10 | ||||
| 2024-09-30 | $991.79M 10-Q · filed 2025-10-28 | $2.51B derived: sum of 2 quarters · filed 2025-10-28 | $3.30B 10-Q · filed 2025-10-28 | $4.13B derived: sum of 4 quarters · filed 2026-02-10 | ||||
| 2024-06-30 | $1.52B 10-Q · filed 2025-07-29 | $2.31B 10-Q · filed 2025-07-29 | $3.14B derived: sum of 3 quarters · filed 2026-02-10 | $3.84B derived: sum of 4 quarters · filed 2026-02-10 | ||||
| 2024-03-31 | $788.99M 10-Q · filed 2025-04-29 | $1.62B derived: sum of 2 quarters · filed 2026-02-10 | $2.32B derived: sum of 3 quarters · filed 2026-02-10 | $3.08B derived: sum of 4 quarters · filed 2026-02-10 | ||||
| 2023-12-31 | $826.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $1.53B derived: sum of 2 quarters · filed 2026-02-10 | $2.29B derived: sum of 3 quarters · filed 2026-02-10 | $3.08B 10-K · filed 2026-02-10 | ||||
| 2023-09-30 | $704.32M 10-Q · filed 2024-10-29 | $1.47B derived: sum of 2 quarters · filed 2024-10-29 | $2.25B 10-Q · filed 2024-10-29 | $3.11B derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2023-06-30 | $760.83M 10-Q · filed 2024-07-30 | $1.54B 10-Q · filed 2024-07-30 | $2.40B derived: sum of 3 quarters · filed 2025-02-10 | $3.09B derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2023-03-31 | $783.90M 10-Q · filed 2024-04-30 | $1.64B derived: sum of 2 quarters · filed 2025-02-10 | $2.33B derived: sum of 3 quarters · filed 2025-02-10 | $2.98B derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2022-12-31 | $856.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $1.54B derived: sum of 2 quarters · filed 2025-02-10 | $2.20B derived: sum of 3 quarters · filed 2025-02-10 | $2.82B 10-K · filed 2025-02-10 | ||||
| 2022-09-30 | $684.93M 10-Q · filed 2023-10-31 | $1.34B derived: sum of 2 quarters · filed 2023-10-31 | $1.96B 10-Q · filed 2023-10-31 | $2.71B derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2022-06-30 | $656.97M 10-Q · filed 2023-08-01 | $1.27B 10-Q · filed 2023-08-01 | $2.03B derived: sum of 3 quarters · filed 2024-02-13 | $2.60B derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2022-03-31 | $616.70M 10-Q · filed 2023-05-02 | $1.37B derived: sum of 2 quarters · filed 2024-02-13 | $1.95B derived: sum of 3 quarters · filed 2024-02-13 | $2.51B derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2021-12-31 | $752.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $1.33B derived: sum of 2 quarters · filed 2024-02-13 | $1.89B derived: sum of 3 quarters · filed 2024-02-13 | $2.40B 10-K · filed 2024-02-13 | ||||
| 2021-09-30 | $577.58M 10-Q · filed 2022-11-01 | $1.14B derived: sum of 2 quarters · filed 2022-11-01 | $1.65B 10-Q · filed 2022-11-01 | $2.27B derived: sum of 4 quarters · filed 2023-02-07 | ||||
| 2021-06-30 | $564.87M 10-Q · filed 2022-08-02 | $1.07B 10-Q · filed 2022-08-02 | $1.70B derived: sum of 3 quarters · filed 2023-02-07 | $2.31B derived: sum of 4 quarters · filed 2023-02-07 | ||||
| 2021-03-31 | $505.92M 10-Q · filed 2022-05-03 | $1.13B derived: sum of 2 quarters · filed 2023-02-07 | $1.75B derived: sum of 3 quarters · filed 2023-02-07 | $2.20B derived: sum of 4 quarters · filed 2023-02-07 | ||||
| 2020-12-31 | $625.28M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $1.24B derived: sum of 2 quarters · filed 2023-02-07 | $1.70B derived: sum of 3 quarters · filed 2023-02-07 | $2.93B 10-K · filed 2023-02-07 | ||||
| 2020-09-30 | $615.32M 10-Q · filed 2021-11-02 | $1.07B derived: sum of 2 quarters · filed 2021-11-02 | $2.31B 10-Q · filed 2021-11-02 | $2.79B derived: sum of 4 quarters · filed 2022-02-08 | ||||
| 2020-06-30 | $457.27M 10-Q · filed 2021-08-03 | $1.69B 10-Q · filed 2021-08-03 | $2.17B derived: sum of 3 quarters · filed 2022-02-08 | $2.59B derived: sum of 4 quarters · filed 2022-02-08 | ||||
| 2020-03-31 | $1.23B 10-Q · filed 2021-05-04 | $1.72B derived: sum of 2 quarters · filed 2022-02-08 | $2.13B derived: sum of 3 quarters · filed 2022-02-08 | $2.57B derived: sum of 4 quarters · filed 2022-02-08 | ||||
| 2019-12-31 | $484.38M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $901.65M derived: sum of 2 quarters · filed 2022-02-08 | $1.33B derived: sum of 3 quarters · filed 2022-02-08 | $1.76B 10-K · filed 2022-02-08 | ||||
| 2019-09-30 | $417.26M 10-Q · filed 2020-11-05 | $848.59M derived: sum of 2 quarters · filed 2020-11-05 | $1.27B 10-Q · filed 2020-11-05 | $1.72B derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2019-06-30 | $431.32M 10-Q · filed 2020-08-04 | $855.11M 10-Q · filed 2020-08-04 | $1.30B derived: sum of 3 quarters · filed 2021-02-09 | $1.72B derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2019-03-31 | $423.79M 10-Q · filed 2020-05-05 | $870.21M derived: sum of 2 quarters · filed 2021-02-09 | $1.29B derived: sum of 3 quarters · filed 2021-02-09 | $1.73B derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2018-12-31 | $446.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $864.99M derived: sum of 2 quarters · filed 2021-02-09 | $1.30B derived: sum of 3 quarters · filed 2021-02-09 | $1.75B 10-K · filed 2021-02-09 | ||||
| 2018-09-30 | $418.56M 10-Q · filed 2019-10-29 | $856.84M derived: sum of 2 quarters · filed 2019-10-29 | $1.31B 10-Q · filed 2019-10-29 | $1.88B derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | $438.28M 10-Q · filed 2019-07-30 | $887.67M 10-Q · filed 2019-07-30 | $1.46B derived: sum of 3 quarters · filed 2020-02-13 | $1.83B derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | $449.39M 10-Q · filed 2019-04-30 | $1.03B derived: sum of 2 quarters · filed 2020-02-13 | $1.39B derived: sum of 3 quarters · filed 2020-02-13 | $1.71B derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | $576.57M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $943.09M derived: sum of 2 quarters · filed 2020-02-13 | $1.26B derived: sum of 3 quarters · filed 2020-02-13 | $1.78B 10-K · filed 2020-02-13 | $1.78B 10-K · filed 2018-02-15 | |||
| 2017-09-30 | $366.51M 10-Q · filed 2018-10-30 | $366.58M 10-Q · filed 2017-10-31 | $685.70M derived: sum of 2 quarters · filed 2018-10-30 | $1.20B 10-Q · filed 2018-10-30 | $1.20B 10-Q · filed 2017-10-31 | $1.49B derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2017-06-30 | $319.19M 10-Q · filed 2018-07-31 | $319.24M 10-Q · filed 2017-08-01 | $836.51M 10-Q · filed 2018-07-31 | $836.63M 10-Q · filed 2017-08-01 | $1.12B derived: sum of 3 quarters · filed 2019-02-14 | $1.37B derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2017-03-31 | $517.33M 10-Q · filed 2018-05-01 | $517.39M 10-Q · filed 2017-05-04 | $801.75M derived: sum of 2 quarters · filed 2019-02-14 | $1.05B derived: sum of 3 quarters · filed 2019-02-14 | $1.25B derived: sum of 4 quarters · filed 2019-02-14 | |||
| 2016-12-31 | $284.42M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $531.60M derived: sum of 2 quarters · filed 2019-02-14 | $733.29M derived: sum of 3 quarters · filed 2019-02-14 | $960.72M 10-K · filed 2019-02-14 | ||||
| 2016-09-30 | $247.18M 10-Q · filed 2017-10-31 | $448.88M derived: sum of 2 quarters · filed 2017-10-31 | $676.30M 10-Q · filed 2017-10-31 | $855.10M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | $201.70M 10-Q · filed 2017-08-01 | $429.13M 10-Q · filed 2017-08-01 | $607.93M derived: sum of 3 quarters · filed 2018-02-15 | $795.64M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | $227.43M 10-Q · filed 2017-05-04 | $406.23M derived: sum of 2 quarters · filed 2018-02-15 | $593.94M derived: sum of 3 quarters · filed 2018-02-15 | $764.32M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | $178.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $366.51M derived: sum of 2 quarters · filed 2018-02-15 | $536.89M derived: sum of 3 quarters · filed 2018-02-15 | $703.10M 10-K · filed 2018-02-15 | ||||
| 2015-09-30 | $187.71M 10-Q · filed 2016-11-01 | $358.09M derived: sum of 2 quarters · filed 2016-11-01 | $524.30M 10-Q · filed 2016-11-01 | $673.90M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-06-30 | $170.38M 10-Q · filed 2016-08-09 | $336.59M 10-Q · filed 2016-08-09 | $486.19M derived: sum of 3 quarters · filed 2017-02-14 | $614.39M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-03-31 | $166.21M 10-Q · filed 2016-05-09 | $315.81M derived: sum of 2 quarters · filed 2017-02-14 | $444.01M derived: sum of 3 quarters · filed 2017-02-14 | $569.78M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2014-12-31 | $149.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $277.80M derived: sum of 2 quarters · filed 2017-02-14 | $403.57M derived: sum of 3 quarters · filed 2017-02-14 | $516.30M 10-K · filed 2017-02-14 | ||||
| 2014-09-30 | $128.20M 10-Q · filed 2015-11-03 | $253.97M derived: sum of 2 quarters · filed 2015-11-03 | $366.70M 10-Q · filed 2015-11-03 | $479.91M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2014-06-30 | $125.77M 10-Q · filed 2015-08-04 | $238.50M 10-Q · filed 2015-08-04 | $351.71M derived: sum of 3 quarters · filed 2016-02-12 | $450.01M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2014-03-31 | $112.73M 10-Q · filed 2015-04-30 | $225.94M derived: sum of 2 quarters · filed 2016-02-12 | $324.25M derived: sum of 3 quarters · filed 2016-02-12 | $408.60M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2013-12-31 | $113.21M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $211.52M derived: sum of 2 quarters · filed 2016-02-12 | $295.88M derived: sum of 3 quarters · filed 2016-02-12 | $371.05M 10-K · filed 2016-02-12 | ||||
| 2013-09-30 | $98.31M 10-Q · filed 2014-10-30 | $182.66M derived: sum of 2 quarters · filed 2014-10-30 | $257.84M 10-Q · filed 2014-10-30 | $341.43M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2013-06-30 | $84.36M 10-Q · filed 2014-07-31 | $159.53M 10-Q · filed 2014-07-31 | $243.12M derived: sum of 3 quarters · filed 2015-02-17 | $313.75M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2013-03-31 | $75.17M 10-Q · filed 2014-05-01 | $158.77M derived: sum of 2 quarters · filed 2015-02-17 | $229.40M derived: sum of 3 quarters · filed 2015-02-17 | $300.72M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2012-12-31 | $83.59M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $154.22M derived: sum of 2 quarters · filed 2015-02-17 | $225.54M derived: sum of 3 quarters · filed 2015-02-17 | $295.91M 10-K · filed 2015-02-17 | ||||
| 2012-09-30 | $70.63M 10-Q · filed 2013-10-31 | $141.95M derived: sum of 2 quarters · filed 2013-10-31 | $212.32M 10-Q · filed 2013-10-31 | $285.35M derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-06-30 | $71.32M 10-Q · filed 2013-08-01 | $141.69M 10-Q · filed 2013-08-01 | $214.72M derived: sum of 3 quarters · filed 2014-02-21 | $273.61M derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-03-31 | $70.37M 10-Q · filed 2013-05-02 | $143.40M derived: sum of 2 quarters · filed 2014-02-21 | $202.28M derived: sum of 3 quarters · filed 2014-02-21 | $260.21M derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2011-12-31 | $73.03M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $131.91M derived: sum of 2 quarters · filed 2014-02-21 | $189.84M derived: sum of 3 quarters · filed 2014-02-21 | $237.64M 10-K · filed 2014-02-21 | ||||
| 2011-09-30 | $58.89M 10-Q · filed 2012-11-01 | $116.81M derived: sum of 2 quarters · filed 2012-11-01 | $164.61M 10-Q · filed 2012-11-01 | $208.17M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-06-30 | $57.92M 10-Q · filed 2012-08-03 | $105.72M 10-Q · filed 2012-08-03 | $149.28M derived: sum of 3 quarters · filed 2013-02-21 | $188.21M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-03-31 | $47.80M 10-Q · filed 2012-04-26 | $91.36M derived: sum of 2 quarters · filed 2013-02-21 | $130.28M derived: sum of 3 quarters · filed 2013-02-21 | $166.51M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2010-12-31 | $43.56M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $82.49M derived: sum of 2 quarters · filed 2013-02-21 | $118.71M derived: sum of 3 quarters · filed 2013-02-21 | $155.83M 10-K · filed 2013-02-21 | ||||
| 2010-09-30 | $38.93M 10-Q · filed 2011-10-27 | $75.15M derived: sum of 2 quarters · filed 2011-10-27 | $112.27M 10-Q · filed 2011-10-27 | |||||
| 2010-06-30 | $36.22M 10-Q · filed 2011-07-28 | $73.34M 10-Q · filed 2011-07-28 | ||||||
| 2010-03-31 | $37.12M 10-Q · filed 2011-05-03 | |||||||
| 2009-12-31 | $149.03M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |